🏛️ Verified NIH Record • Updated 2026-07-23
Shortened LSD Intervention for Major Depressive Disorder (NCT07503002)
🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: Johns Hopkins University
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine the safety and clinical effectiveness of a shortened lysergic acid diethylamide (LSD) experience. This will be achieved by administering the drug risperidone 45-minutes after the administration of LSD.
Who can join: Review the eligibility criteria below.
Location: Johns Hopkins Center for Psychedelic and Consciousness Research — Baltimore, Maryland
Age range: 21 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Johns Hopkins Center for Psychedelic and Consciousness Research — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (410) 999-8066
Email: slimstudy@jh.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Major Depression Moderate
- rTMS for Youth Inpatients With Depression — Toronto, Ontario
Explore by condition: All Major Depression Moderate clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.